Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Feb;85(3):802–806. doi: 10.1073/pnas.85.3.802

Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells.

D E Pettijohn 1, O Pfenninger 1, J Brown 1, R Duke 1, L Olsson 1
PMCID: PMC279643  PMID: 3422461

Abstract

Cells of cloned lines derived from human squamous lung carcinomas spontaneously become heterogeneous with respect to several tumor-associated cell surface carbohydrates such as the sialosyl-Lea oligosaccharide antigen or the recently described oligosaccharide recognized by monoclonal antibody 43-9F. Subclones derived from these cultures are initially homogeneous with respect to the presence or absence of a specific cell surface carbohydrate but gradually revert back to a heterogeneous population. Cells of homogeneous subclones having both the sialosyl-LEa and 43-9F cell surface antigens and other subclones lacking them were injected subcutaneously in nude mice. All clones expressing these tumor-associated cell surface carbohydrates were found to be highly tumorigenic, whereas those lacking them were nontumorigenic or, at most, weakly tumorigenic. Clones having the tumor-associated cell surface carbohydrates were more resistant to cytotoxic attack by purified mouse natural killer cells than those clones lacking these carbohydrates, suggesting that the tumorigenicity of the former clones may be influenced by immunoprotective effects of these novel carbohydrates.

Full text

PDF
802

Images in this article

804Image
on p.804

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. 16th International Leukocyte Culture Conference. August 19-25, 1984, Cambridge. Abstracts. Immunobiology. 1984 Aug;167(1-3):1–292. [PubMed] [Google Scholar]
  2. Ahrens P. B., Ankel H. The role of asparagine-linked carbohydrate in natural killer cell-mediated cytolysis. J Biol Chem. 1987 Jun 5;262(16):7575–7579. [PubMed] [Google Scholar]
  3. Berthier-Vergnes O., Portoukalian J., Doré J. F. Expression of cell surface glycoproteins in human melanoma cell lines with different tumorigenic properties. Int J Cancer. 1985 Oct 15;36(4):461–466. doi: 10.1002/ijc.2910360408. [DOI] [PubMed] [Google Scholar]
  4. Berthier-Vergnes O., Portoukalian J., Doré J. F. Organization and neuraminidase susceptibility of sialic acid residues in human melanoma cell lines with different heterotransplantabilities in nude mice. J Natl Cancer Inst. 1985 Oct;75(4):605–611. [PubMed] [Google Scholar]
  5. Blaszczyk M., Hansson G. C., Karlsson K. A., Larson G., Stromberg N., Thurin J., Herlyn M., Steplewski Z., Koprowski H. Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. Arch Biochem Biophys. 1984 Aug 15;233(1):161–168. doi: 10.1016/0003-9861(84)90612-x. [DOI] [PubMed] [Google Scholar]
  6. Chia D., Terasaki P. I., Suyama N., Galton J., Hirota M., Katz D. Use of monoclonal antibodies to sialylated Lewisx and sialylated Lewisa for serological tests of cancer. Cancer Res. 1985 Jan;45(1):435–437. [PubMed] [Google Scholar]
  7. Dennis J. W., Laferté S. Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells. Cancer Res. 1985 Dec;45(12 Pt 1):6034–6040. [PubMed] [Google Scholar]
  8. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 1985 Mar 7;314(6006):53–57. doi: 10.1038/314053a0. [DOI] [PubMed] [Google Scholar]
  9. Fukushi Y., Kannagi R., Hakomori S., Shepard T., Kulander B. G., Singer J. W. Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res. 1985 Aug;45(8):3711–3717. [PubMed] [Google Scholar]
  10. Grönberg A., Eriksson E., Sinangil F., Rönnholm M., Feizi T., Minden P., Kiessling R. Comparison between murine natural antibodies and natural killer cells: recognition of separate target structures as revealed by differential in vitro expression and dependence on glycosylation. J Natl Cancer Inst. 1985 Jan;74(1):67–75. [PubMed] [Google Scholar]
  11. Habu S., Fukui H., Shimamura K., Kasai M., Nagai Y., Okumura K., Tamaoki N. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol. 1981 Jul;127(1):34–38. [PubMed] [Google Scholar]
  12. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985 Jun;45(6):2405–2414. [PubMed] [Google Scholar]
  13. Hakomori S., Andrews H. D. Sphingoglycolipids with Leb activity, and the co-presence of Lea-, Leb-glycolipids in human tumor tissue. Biochim Biophys Acta. 1970 Feb 10;202(1):225–228. doi: 10.1016/0005-2760(70)90244-4. [DOI] [PubMed] [Google Scholar]
  14. Hakomori S., Nudelman E., Levery S. B., Kannagi R. Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J Biol Chem. 1984 Apr 10;259(7):4672–4680. [PubMed] [Google Scholar]
  15. Harel-Bellan A., Quillet A., Marchiol C., DeMars R., Tursz T., Fradelizi D. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5688–5692. doi: 10.1073/pnas.83.15.5688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Herberman R. B., Reynolds C. W., Ortaldo J. R. Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol. 1986;4:651–680. doi: 10.1146/annurev.iy.04.040186.003251. [DOI] [PubMed] [Google Scholar]
  17. Houghton A. N., Mintzer D., Cordon-Cardo C., Welt S., Fliegel B., Vadhan S., Carswell E., Melamed M. R., Oettgen H. F., Old L. J. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1242–1246. doi: 10.1073/pnas.82.4.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  19. Koprowski H., Herlyn M., Steplewski Z., Sears H. F. Specific antigen in serum of patients with colon carcinoma. Science. 1981 Apr 3;212(4490):53–55. doi: 10.1126/science.6163212. [DOI] [PubMed] [Google Scholar]
  20. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979 Nov;5(6):957–971. doi: 10.1007/BF01542654. [DOI] [PubMed] [Google Scholar]
  21. Ljunggren H. G., Kärre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med. 1985 Dec 1;162(6):1745–1759. doi: 10.1084/jem.162.6.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lydersen B. K., Pettijohn D. E. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell. Cell. 1980 Nov;22(2 Pt 2):489–499. doi: 10.1016/0092-8674(80)90359-1. [DOI] [PubMed] [Google Scholar]
  23. Magnani J. L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 1982 Dec 10;257(23):14365–14369. [PubMed] [Google Scholar]
  24. Olsson L., Sorensen H. R., Behnke O. Intratumoral phenotypic diversity of cloned human lung tumor cell lines and consequences for analyses with monoclonal antibodies. Cancer. 1984 Nov 1;54(9):1757–1765. doi: 10.1002/1097-0142(19841101)54:9<1757::aid-cncr2820540902>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  25. Pettijohn D. E., Stranahan P. L., Due C., Rønne E., Sørensen H. R., Olsson L. Glycoproteins distinguishing non-small cell from small cell human lung carcinoma recognized by monoclonal antibody 43-9F. Cancer Res. 1987 Feb 15;47(4):1161–1169. [PubMed] [Google Scholar]
  26. Pohajdak B., Lee K. C., Sugawara I., Miller V., Wright J. A., Greenberg A. H. Comparative analysis of natural killer cell and macrophage recognition of concanavalin A-resistant Chinese hamster ovary cells: role of membrane oligosaccharides. J Natl Cancer Inst. 1986 Feb;76(2):257–267. [PubMed] [Google Scholar]
  27. Price C. M., Pettijohn D. E. Redistribution of the nuclear mitotic apparatus protein (NuMA) during mitosis and nuclear assembly. Properties of purified NuMA protein. Exp Cell Res. 1986 Oct;166(2):295–311. doi: 10.1016/0014-4827(86)90478-7. [DOI] [PubMed] [Google Scholar]
  28. Reynolds C. W., Timonen T., Herberman R. B. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol. 1981 Jul;127(1):282–287. [PubMed] [Google Scholar]
  29. Steplewski Z., Sears H. F., Koprowski H. Monoclonal antibody infusion in gastrointestinal cancer patients. Recent Results Cancer Res. 1986;100:321–323. doi: 10.1007/978-3-642-82635-1_40. [DOI] [PubMed] [Google Scholar]
  30. Stutman O., Dien P., Wisun R. E., Lattime E. C. Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose. Proc Natl Acad Sci U S A. 1980 May;77(5):2895–2898. doi: 10.1073/pnas.77.5.2895. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES